Halo Technologies Holdings Limited (ASX:HAL)

Intra-Cellular Therapies Income Statement

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest and Dividend Income	0.29	0.56	0.5	0	0.04
Total Interest Expense	0.08	0.02	0.19	0.23	0.47
Net Interest Income	0.21	0.54	0.31	-0.22	-0.43
Brokerage Commission	15.21	8.05	4.45	2.91	4.7
Other Revenue	3.53	4.83	5.17	2.09	0.73
Revenue Before Loan Losses	18.96	13.42	9.93	4.78	5
Provision for Loan Losses	-0.1	-	-	-	-
Revenue	19.06	13.42	9.93	4.78	5
Revenue Growth (YoY)	41.99%	35.14%	107.98%	-4.47%	322.21%
Salaries & Employee Benefits	5.74	2.95	2.29	0.23	-
Cost of Services Provided	22.92	14.6	9.74	4.3	0.17
Other Operating Expenses	2.08	-0.47	-1.05	-0.52	3.59
Total Operating Expenses	32.34	18.39	11.69	4.3	3.75
Operating Income	-13.28	-4.97	-1.76	0.48	1.25
EBT Excluding Unusual Items	-13.28	-4.97	-1.76	0.48	1.25
Gain (Loss) on Sale of Investments	-1.1	-2.91	-	-0.27	-
Other Unusual Items	-	-	-	2.31	-
Pretax Income	-14.37	-7.88	-1.76	2.51	1.25
Income Tax Expense	0.17	-0.67	0.27	0.13	0.08
Net Income	-14.54	-7.2	-2.03	2.38	1.17
Net Income to Common	-14.54	-7.2	-2.03	2.38	1.17
Net Income Growth	-	-	-	103.08%	536.96%
Shares Outstanding (Basic)	129	129	123	104	-
Shares Outstanding (Diluted)	129	129	123	104	-
Shares Change (YoY)	-0.55%	5.66%	17.66%	-	-
EPS (Basic)	-0.11	-0.06	-0.02	0.02	-
EPS (Diluted)	-0.11	-0.06	-0.02	0.02	-
Free Cash Flow	-5.93	-4.11	-3.34	2.57	-
Free Cash Flow Per Share	-0.05	-0.03	-0.03	0.03	-
Operating Margin	-69.68%	-37.02%	-17.70%	9.95%	24.95%
Profit Margin	-76.31%	-53.68%	-20.40%	49.84%	23.45%
Free Cash Flow Margin	-31.11%	-30.59%	-33.62%	53.86%	-
Effective Tax Rate	-	-	-	5.21%	6.01%
Revenue as Reported	19.04	14.23	11.35	7.88	-

Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.